Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP302128.RASfSOn42tRwd7h3ieGJr3YhzRTt4nOVjqTtUkxCkOxkg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP302128.RASfSOn42tRwd7h3ieGJr3YhzRTt4nOVjqTtUkxCkOxkg130_assertion type Assertion NP302128.RASfSOn42tRwd7h3ieGJr3YhzRTt4nOVjqTtUkxCkOxkg130_head.
- NP302128.RASfSOn42tRwd7h3ieGJr3YhzRTt4nOVjqTtUkxCkOxkg130_assertion description "[These assays demonstrated expression and activation of the AXL protein, which is an RTK with known oncogenic properties in non-mesothelial cancer types.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP302128.RASfSOn42tRwd7h3ieGJr3YhzRTt4nOVjqTtUkxCkOxkg130_provenance.
- NP302128.RASfSOn42tRwd7h3ieGJr3YhzRTt4nOVjqTtUkxCkOxkg130_assertion evidence source_evidence_literature NP302128.RASfSOn42tRwd7h3ieGJr3YhzRTt4nOVjqTtUkxCkOxkg130_provenance.
- NP302128.RASfSOn42tRwd7h3ieGJr3YhzRTt4nOVjqTtUkxCkOxkg130_assertion SIO_000772 21132014 NP302128.RASfSOn42tRwd7h3ieGJr3YhzRTt4nOVjqTtUkxCkOxkg130_provenance.
- NP302128.RASfSOn42tRwd7h3ieGJr3YhzRTt4nOVjqTtUkxCkOxkg130_assertion wasDerivedFrom befree-20140225 NP302128.RASfSOn42tRwd7h3ieGJr3YhzRTt4nOVjqTtUkxCkOxkg130_provenance.
- NP302128.RASfSOn42tRwd7h3ieGJr3YhzRTt4nOVjqTtUkxCkOxkg130_assertion wasGeneratedBy ECO_0000203 NP302128.RASfSOn42tRwd7h3ieGJr3YhzRTt4nOVjqTtUkxCkOxkg130_provenance.